文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

基于艾司氯胺酮的无阿片麻醉减轻腹腔镜手术患者术后恶心呕吐:一项随机双盲多中心试验的研究方案

Esketamine-based opioid-free anaesthesia alleviates postoperative nausea and vomiting in patients who underwent laparoscopic surgery: study protocol for a randomized, double-blinded, multicentre trial.
PubMed 文献 · Trials · 2023-01-06

本研究为前瞻性随机对照多中心试验,计划纳入278例18-50岁非吸烟女性腹腔镜阑尾切除或胆囊切除患者,比较艾司氯胺酮与舒芬太尼术中镇痛对术后3天恶心呕吐发生率的影响,主要结局为PONV发生率,次要结局包括恢复状态、疼痛、镇静、谵妄与认知、焦虑抑郁及镇痛药总消耗量。

要点

  • 研究比较艾司氯胺酮无阿片麻醉与舒芬太尼麻醉,主要结局为术后3天PONV发生率。
  • 纳入278例18-50岁非吸烟女性腹腔镜阑尾切除或胆囊切除患者,ASA I-III级。
  • 试验注册于中国临床试验注册中心ChiCTR2100047169,注册日期2021年6月9日。

核心结论

  • 该试验可能显示艾司氯胺酮与丙泊酚麻醉的协同作用减少PONV及其他短期不良事件,从而为腹腔镜阑尾切除和胆囊切除的ERAS提供更好的安全性和满意度。

研究设计与样本

  • 前瞻性、随机、对照、多中心试验,共纳入278例患者。
  • 纳入标准为非吸烟女性,年龄18-50岁,拟行腹腔镜阑尾切除或胆囊切除,ASA I-III级,无严重躯体或精神疾病。
  • 两组均接受常规围术期护理,仅镇痛药物分别为艾司氯胺酮或舒芬太尼。
  • 主要结局为术后3天PONV发生率;次要结局包括恢复状态、疼痛、镇静水平及整体恢复、谵妄与认知、焦虑与抑郁及镇痛药总消耗量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although opioids are commonly prescribed in clinical anaesthesia, the significant side effects attributed to their overuse are raising increasing concerns. One way to reduce perioperative opioid consumption is to apply opioid-reduced anaesthesia (ORA) and even opioid-free anaesthesia (OFA), which involves regional techniques, neuraxial anaesthesia, nonopioid analgesics or combined use. The aim of this study was to investigate whether the application of OFA by using esketamine in intraoperative analgesia could minimize the side effects of postoperative nausea and vomiting (PONV), as well as other short-term side effects related to anaesthesia. METHODS/DESIGN: The study was designed as a prospective, randomized, controlled, multicentre trial. A total of 278 patients were enrolled; participants were nonsmoking female patients aged 18-50 years and scheduled for laparoscopic appendectomy or cholecystectomy, ASA at I-III, with no serious physical or mental diseases. Both groups received usual perioperative care except for the analgesic medication of either esketamine or sufentanil. The primary outcome was the incidence of PONV 3 days after surgery. Secondary outcomes included recovery status, pain, sedation level and overall recovery, delirium and cognition, anxiety and depression and total consumption of analgesic agents. DISCUSSION: This trial may show that the synergy of esketamine and propofol anaesthesia reduces PONV as well as other short-term adverse events, thereby providing a better safety and satisfaction profile of ERAS for laparoscopic appendectomy and cholecystectomy. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2100047169. Registered on June 9, 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chen HY, Meng XY, Gao H, et al. Esketamine-based opioid-free anaesthesia alleviates postoperative nausea and vomiting in patients who underwent laparoscopic surgery: study protocol for a randomized, double-blinded, multicentre trial. Trials. 2023. PMID: 36609307. doi:10.1186/s13063-022-07003-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。